Bacterial cell wall and associated biosynthetic enzymes

The bacterial cell wall is a complex, rigid structure primarily composed of peptidoglycan that provides structural integrity and protects bacteria from osmotic pressure [PMID: 28258208]. It serves as a critical therapeutic target because its components, such as the enzymes involved in its synthesis (e.g., penicillin-binding proteins) and various adhesion proteins, are often unique to prokaryotes, allowing for selective toxicity [StatPearls: NBK538277]. Drugs targeting the cell wall, such as beta-lactams and glycopeptides, typically interfere with the cross-linking of peptidoglycan chains or the transport of precursors, leading to cell lysis and death [PMID: 26916278]. Additionally, bacterial adhesion proteins are essential for the colonization of host tissues and the formation of biofilms, making them targets for anti-adhesive therapies [PMID: 30105218]. Targeting multiple enzymes and structural components simultaneously is a common strategy to enhance efficacy and reduce the likelihood of resistance development [PMID: 24514411]. This broad target profile is central to the treatment of a wide range of gram-positive and gram-negative bacterial infections [PMID: 28258208].

Other names

Peptidoglycan layerBacterial cell wall machineryCell wall biosynthetic enzymesBacterial surface adhesion proteins

Inhibition of peptidoglycan cross-linking by binding to penicillin-binding proteins (PBPs), inhibition of cell wall precursor transport, or disruption of bacterial adhesion to host surfaces [PMID: 26916278, PMID: 28258208].